CareCost Estimate
The Infusion Reimbursement Index · Q2 2026 · v2.0

Wellmark BCBS (Iowa/South Dakota)

CareCost Research · Reviewed by Erin Rose

Scorecard

Grade
C
Index (ASP = 100)
100.0
Vs. acquisition
-2.6%
Brand index
100.0
Biosimilar index
113.6
Contract variability
Low
Drugs observed
908
States
10

Contracts below the typical acquisition benchmark (102.7) on the median drug.

How this payer prices

On this filing, the median drug carries 2 distinct contracted rates across practices, with 99% of billing volume on the single most common rate — an effectively posted price.

Benchmarks: typical acquisition 102.7 · Medicare 104.3 after sequestration · 106 statutory (ASP = 100).

Contracted rates from insurers’ machine-readable files, not amounts paid on a claim.